BYVALSON FDA approval date

The FDA approved BYVALSON on 3 Jun 2016.

FDA approval date
3 Jun 2016

Drug identity has not yet been verified against registry records

Also recorded as NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-06-03DayBYVALSONFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206302", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["BYVALSON"], "active_ingredients": ["NEBIVOLOL HYDROCHLORIDE", "VALSARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160603", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026